COVID-19 outbreak and cancer radiotherapy disruption in Italy: survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
- Barbara Alicja Jereczek-Fossa
- Matteo Pepa
- Giulia Marvaso
- Alessio Bruni
- Michela Buglione di Monale e Bastia
- Gianpiero Catalano
- Andrea Riccardo Filippi
- Pierfrancesco Franco
- Maria Antonietta Gambacorta
- Domenico Genovesi
- Giuseppe Iatì
- Alessandro Magli
- Luigi Marafioti
- Icro Meattini
- Anna Merlotti
- Marcello Mignogna
- Daniela Musio
- Roberto Pacelli
- Stefano Pergolizzi
- Vincenzo Tombolini
- Marco Trovò
- Umberto Ricardi
- Stefano Maria Magrini
- Renzo Corvò
- Vittorio Donato
DOIAbstract
Italy experienced one of the world's deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety
Add to ORKG